Published in Behav Neurol on January 01, 2013
Individual differences in approach-avoidance aptitude: some clues from research on Parkinson's disease. Front Syst Neurosci (2015) 0.81
Perceptual, cognitive, and personality rigidity in Parkinson's disease. Neuropsychologia (2015) 0.78
Personality and addictive behaviours in early Parkinson's disease and REM sleep behaviour disorder. Parkinsonism Relat Disord (2017) 0.75
Personality and reported quality of life in Parkinson's disease. Int J Geriatr Psychiatry (2016) 0.75
Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol (2005) 2.54
Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 2.23
Handedness correlates with the dominant Parkinson side: a systematic review and meta-analysis. Mov Disord (2011) 1.84
Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol (2002) 1.45
Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol Aging (2008) 1.30
Chorein detection for the diagnosis of chorea-acanthocytosis. Ann Neurol (2004) 1.28
Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord (2010) 1.22
The history of attention deficit hyperactivity disorder. Atten Defic Hyperact Disord (2010) 1.16
Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations. Brain (2009) 1.15
Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study. Mov Disord (2006) 1.09
Executive functions in children with dyslexia. Dyslexia (2005) 1.07
Validation of parkinsonian disease-related metabolic brain patterns. Mov Disord (2013) 1.06
Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET. Mov Disord (2007) 1.05
Brain imaging in patients with freezing of gait. Mov Disord (2008) 1.04
Risky behavior in gambling tasks in individuals with ADHD--a systematic literature review. PLoS One (2013) 1.00
Simultaneous EMG-functional MRI recordings can directly relate hyperkinetic movements to brain activity. Hum Brain Mapp (2008) 0.99
Late-onset Huntington disease with intermediate CAG repeats: true or false? J Neurol Neurosurg Psychiatry (2010) 0.99
Striatal dopa and glucose metabolism in PD patients with freezing of gait. Mov Disord (2006) 0.99
Vigilance and sustained attention in children and adults with ADHD. J Atten Disord (2008) 0.99
Parkinson's disease: the syndrome, the pathogenesis and pathophysiology. Cortex (2008) 0.98
Genetics of early-onset obsessive-compulsive disorder. Eur Child Adolesc Psychiatry (2010) 0.97
Stigma in attention deficit hyperactivity disorder. Atten Defic Hyperact Disord (2012) 0.96
Metabolic network as a progression biomarker of premanifest Huntington's disease. J Clin Invest (2013) 0.95
The impact of executive functions on verb production in patients with Parkinson's disease. Cortex (2009) 0.93
Changed patterns of cerebral activation related to clinically normal hand movement in cervical dystonia. Clin Neurol Neurosurg (2007) 0.92
Cerebral activation during motor imagery in complex regional pain syndrome type 1 with dystonia. Pain (2007) 0.92
Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage (2003) 0.90
Striatal FDOPA uptake and cognition in advanced non-demented Parkinson's disease: a clinical and FDOPA-PET study. Parkinsonism Relat Disord (2008) 0.89
Brain dopamine and kinematics of graphomotor functions. Hum Mov Sci (2006) 0.89
Neural networks of response shifting: influence of task speed and stimulus material. Brain Res (2006) 0.89
Animal models of attention deficit/hyperactivity disorder (ADHD): a critical review. Atten Defic Hyperact Disord (2010) 0.89
Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration. Curr Neuropharmacol (2010) 0.88
Language and Parkinson's disease. Cortex (2009) 0.88
Cerebral activation patterns related to initiation and inhibition of hand movement. Neuroreport (2007) 0.88
Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD. World J Biol Psychiatry (2012) 0.87
Is moderate substance use associated with altered executive functioning in a population-based sample of young adults? Hum Psychopharmacol (2009) 0.87
Abnormal parietal function in conversion paresis. PLoS One (2011) 0.87
TCH346 prevents motor symptoms and loss of striatal FDOPA uptake in bilaterally MPTP-treated primates. Neurobiol Dis (2003) 0.86
1H magnetic resonance spectroscopy in preclinical Huntington disease. Brain Res (2007) 0.86
Measurement of stigmatization towards adults with attention deficit hyperactivity disorder. PLoS One (2012) 0.86
Handedness and dominant side of symptoms in Parkinson's disease. Parkinsonism Relat Disord (2010) 0.85
MDR1 variants and risk of Parkinson disease. Association with pesticide exposure? J Neurol (2009) 0.85
Training of attention functions in children with attention deficit hyperactivity disorder. Atten Defic Hyperact Disord (2011) 0.85
Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease. Eur J Neurosci (2007) 0.84
Cognitive dysfunction in non-demented Parkinson's disease patients: controlled and automatic behavior. Cortex (2009) 0.84
Is levodopa toxic? J Neurol (2004) 0.84
Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease. Mov Disord (2005) 0.84
Executive functioning in daily life in Parkinson's disease: initiative, planning and multi-task performance. PLoS One (2011) 0.83
Coping strategies and IQ in psychogenic movement disorders and paralysis. Mov Disord (2009) 0.83
Differential effects of methylphenidate on problem solving in adults with ADHD. J Atten Disord (2010) 0.83
Time estimation in Parkinson's disease and degenerative cerebellar disease. Neuroreport (2008) 0.82
Cognitive functioning in patients treated for nonfunctioning pituitary macroadenoma and the effects of pituitary radiotherapy. Clin Endocrinol (Oxf) (2011) 0.82
Circadian rhythms in obsessive-compulsive disorder. J Neural Transm (Vienna) (2012) 0.82
The influence of cognitive reserve on cognition in Parkinson's disease. J Neural Transm (Vienna) (2012) 0.82
Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations. Neurogenetics (2011) 0.82
Prefrontal cortex and striatal activation by feedback in Parkinson's disease. Brain Res (2008) 0.81
Difficulties in Daily Life Reported by Patients With Homonymous Visual Field Defects. J Neuroophthalmol (2015) 0.81
Differences in the EMG pattern of leg muscle activation during locomotion in Parkinson's disease. Funct Neurol (2004) 0.81
Putamen FDOPA uptake and its relationship tot cognitive functioning in PD. J Neurol Sci (2006) 0.81
Processing of continuously provided punishment and reward in children with ADHD and the modulating effects of stimulant medication: an ERP study. PLoS One (2013) 0.81
Detrimental effects of gum chewing on vigilance in children with attention deficit hyperactivity disorder. Appetite (2010) 0.81
Benign childhood epilepsy with centrotemporal spikes and the multicomponent model of attention: a matched control study. Epilepsy Behav (2010) 0.81
Complex prospective memory in adults with attention deficit hyperactivity disorder. PLoS One (2013) 0.81
Attention impairment in childhood absence epilepsy: an impulsivity problem? Epilepsy Behav (2013) 0.80
Whole-body vibration improves cognitive functions of an adult with ADHD. Atten Defic Hyperact Disord (2014) 0.80
Changes in cerebral activations during movement execution and imagery after parietal cortex TMS interleaved with 3T MRI. Brain Res (2009) 0.80
What is measured with verbal fluency tests in Parkinson's disease patients at different stages of the disease? J Neural Transm (Vienna) (2012) 0.80
[Children and adolescents with obsessive-compulsive disorders]. Z Kinder Jugendpsychiatr Psychother (2009) 0.80
Spatial memory in spontaneously hypertensive rats (SHR). PLoS One (2013) 0.80
Complaints about impairments in executive functions in Parkinson's disease: the association with neuropsychological assessment. Parkinsonism Relat Disord (2011) 0.79
Narrowing wide-field optic flow affects treadmill gait in left-sided Parkinson's disease. Mov Disord (2011) 0.79
Cerebral activations related to ballistic, stepwise interrupted and gradually modulated movements in Parkinson patients. PLoS One (2012) 0.79
Is FDG-PET a useful tool in clinical practice for diagnosing corticobasal ganglionic degeneration? Mov Disord (2003) 0.79
Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease. J Neurol (2014) 0.78
PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomas. J Nucl Med (2002) 0.78
Coherence analysis differentiates between cortical myoclonic tremor and essential tremor. Mov Disord (2006) 0.78
Effects of DSP4 and methylphenidate on spatial memory performance in rats. Atten Defic Hyperact Disord (2011) 0.78
Effects of previous growth hormone excess and current medical treatment for acromegaly on cognition. Eur J Clin Invest (2012) 0.78
In vivo binding behavior of dopamine receptor agonist (+)-PD 128907 and implications for the "ceiling effect" in endogenous competition studies with [(11)C]raclopride-a positron emission tomography study in Macaca mulatta. J Cereb Blood Flow Metab (2004) 0.78
Attentional and perceptual impairments in Parkinson's disease with visual hallucinations. Parkinsonism Relat Disord (2010) 0.78
Quantifying interhemispheric symmetry of somatosensory evoked potentials with the intraclass correlation coefficient. J Clin Neurophysiol (2008) 0.78
Direction of movement is encoded in the human primary motor cortex. PLoS One (2011) 0.77
Source discrimination in adults with attention deficit hyperactivity disorder. PLoS One (2013) 0.77
Subjective and objective assessment of executive functions in Parkinson's disease. J Neurol Sci (2011) 0.77
The effects of the neurotoxin DSP4 on spatial learning and memory in Wistar rats. Atten Defic Hyperact Disord (2012) 0.77
Reduced parietal activation in cervical dystonia after parietal TMS interleaved with fMRI. Clin Neurol Neurosurg (2012) 0.77
Hydrocortisone Dose Influences Pain, Depressive Symptoms and Perceived Health in Adrenal Insufficiency: A Randomized Controlled Trial. Neuroendocrinology (2015) 0.77